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Background: Gene Set Analysis (GSA) has proven to be a useful approach to microarray analysis. However, most of
the method development for GSA has focused on the statistical tests to be used rather than on the generation of
sets that will be tested. Existing methods of set generation are often overly simplistic. The creation of sets from
individual pathways (in isolation) is a poor reflection of the complexity of the underlying metabolic network. We
have developed a novel approach to set generation via the use of Principal Component Analysis of the Laplacian
matrix of a metabolic network. We have analysed a relatively simple data set to show the difference in results
between our method and the current state-of-the-art pathway-based sets.
Results: The sets generated with this method are semi-exhaustive and capture much of the topological complexity
of the metabolic network. The semi-exhaustive nature of this method has also allowed us to design a
hypergeometric enrichment test to determine which genes are likely responsible for set significance. We show that
our method finds significant aspects of biology that would be missed (i.e. false negatives) and addresses the false
positive rates found with the use of simple pathway-based sets.
Conclusions: The set generation step for GSA is often neglected but is a crucial part of the analysis as it defines
the full context for the analysis. As such, set generation methods should be robust and yield as complete a
representation of the extant biological knowledge as possible. The method reported here achieves this goal and is
demonstrably superior to previous set analysis methods.Background
Gene Set Analysis (GSA) has proven to be a useful ap-
proach to microarray analysis. The underlying principle of
GSA is that aggregate scores are assigned to each Gene
Set based on all the individual gene scores within that set.
There have been several different methods proposed to as-
sign scores to gene sets [1-8]. Of the approaches published
to date, Gene Set Enrichment Analysis (GSEA) [3] [7]
seems to have become the most commonly used. Of issue
though is the fact that GSEA is based on a modified
Kolmogorov-Smirnov test. This test can exhibit a lack of
sensitivity; is difficult to employ in practical use, and
requires at least 1000 permutations to be run. However, it
has recently been found [9] that a one-sample Z-test can
be very effective with gene sets for detecting shifts from* Correspondence: jacobson@sun.ac.za
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distribution, and reproduction in any mediumthe mean (sets that collectively show up or down regula-
tion of their constituent genes). Unfortunately, this will
not identify gene sets that have a balance of both up and
down regulated genes as there will not be the requisite
shift from the mean but in statistical terms is rather a
change in scale. However, a chi-squared test can be used
to good effect to detect such changes in scale and thus
find gene sets that exhibit a mixture of up and down regu-
lation [9]. Furthermore, Irizarry et al. [9] have shown that
the use of a combination of the computationally simple
and rapid Z-test and chi-squared methods outperform
GSEA. Dinu et al. [10]have extended the Significance Ana-
lysis of Microarrays to Gene Set Analysis (SAM-GS). Of
further interest is the method described by Efron and Tib-
shirani [11]which uses a max-mean statistic to target gene
sets with only a fraction of the genes differentially
expressed and the approach of Falcon and Gentleman [12]
which takes into account the fact that overlap existsed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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statistical approaches has been written by Goeman and
Bühlmann [13].
Gene set generation
Given the discussion above it is clear that considerable
effort has been made to apply different statistical meth-
ods to GSA, however all of the methods are highly
dependent on the very first step: the predefinition of the
sets of genes to be analysed. The theoretical combinator-
ial space for gene sets is quite large and is defined by the
binomial distribution of the number of genes in the gen-





set size! genes set sizeð Þ!
Thus, if one wanted to create all of the possible unique
sets with 8 members for the ~6000 genes present in the
yeast genome, there would be (6000 choose 8) = 4.1 × 1025
sets. This is clearly an unfeasible number of sets to gener-
ate, much less evaluate. Instead, methods to date have used
extant biological knowledge to generate relatively small
numbers of sets to be evaluated. One of the common
approaches taken for set generation is to simply place the
genes involved in a specific pathway into a set. ThisFigure 1 Location of the sets of nodes derived from the first three pr
network, topographically depicted on the metabolic network itself.approach suffers from the fact that pathways are merely
human abstractions that are useful for visualisation and in-
terpretation, as they can serve as mnemonic devices for
areas of metabolism. However, in isolation, single pathway
sets do not reflect the continuously connected nature of
biological networks. The metabolic network of Saccharo-
myces cerevisiae (and the location of some of the gene sets
found by PCA) can be seen in Figure 1. It is clear that this
is a complex, interconnected network and, as such, any at-
tempt to use simple pathway representations of it will inev-
itably be an incomplete representation of the underlying
network. We therefore propose that many “pathway sets”
are, by definition, rather arbitrary and incomplete, and
gene expression patterns may therefore be potentially
missed due to improper/incomplete set generation. We
suggest that a method that semi-exhaustively partitions the
network into overlapping sets would be a better approach
to set generation. In order to achieve this we have devised
two algorithms that use the Principal Component Analysis
of a Laplacian matrix of a metabolic network to do gene
set generation. We have also devised a hypergeomtric test
to determine which of the genes in the sets identified by
gene set analysis are likely to be driving set selection. We
have used the resulting gene sets to analyse a publicly avail-
able microarray dataset and compare the results obtained
from our algorithms (and their respective parameters) toincipal components of the laplacian matrix of the metabolic
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pathway sets.
It is important to note that our intent in this paper is
not to compare GSA methods to standard parametric
statistical approaches (such as t-tests) as there is ample
literature on GSA to show its usefulness in difficult data-
sets (in which there are many orthogonal factors at play
which can make a dataset difficult to analyse with other
approaches). Rather, our intent is to select a relatively
simple dataset with which to make the point that the
existing state-of-the-art GSA methods that use isolated
pathways are very prone to miss significant amounts of
the signal (as they are not capturing the entire metabolic
set space) and to report insignificant genes as they are
simply associated with a set that is deemed to be collect-
ively significant. As such, both the false negative and
false positive (due to “passenger” genes) rates of GSA
are high when using isolated pathways. We believe that
we have shown that we can address these issues with
our method. To demonstrate this we have chosen a
straightforward, publicly available dataset with a simple
perturbation for which this can easily be demonstrated.
We have used this dataset to simply highlight the differ-
ences in the results generated by our method rather than
to do a full-blown biological interpretation of the micro-
array results.
Methods
Affymetrix probeset to yeast genome mapping
The sequences for each of the individual probes of the
Affymetrix Yeast 2.0 Genechip were mapped to the Yeast
Genome by the use of blastn [14]. A Perl program was
written to perform the following tasks: 1) extract 100%
identity matches (over the full length of the probe) from
the blastn results; 2) assemble the probes into probesets
and 3.) model the resultant probeset-to-gene relation-
ships as an Affymetrix-probeset-to-Genome graph.
Single pathway set creation
In order to compare our method to how GSA of path-
ways has been done in the past it was necessary to create
single pathway-specific sets. A Perl program was written
to parse the XML files downloaded on June 27, 2011
from KEGG [15] and the genes listed in each pathway
file were used to create a simple set for each pathway.
This is analogous to how pathway sets have been created
for GSA previously.
Metabolic network and Laplacian matrix creation
A Perl program was written to parse the XML files
downloaded on June 27, 2011 from KEGG [15]. Nodes
were created for compounds, reactions and genes, and
edges created between genes and the reactions they are
involved in as well as between compounds and thereactions they are substrates for or products of. The re-
sult of this process can be seen in Figure 1 as visualised
by Cytoscape [16]. The resulting metabolic network was
used for all subsequent set generation. A reference struc-
ture within the Perl program which reflected the nodes
and edges in the graph was used to identify adjacency
and degree parameters for each node and thus generate
the corresponding Laplacian matrix.
Principal component analysis
Principal component analysis of the Laplacian matrix
was done in R with the prcomp function. Qlucore v2.2
(Lund, Sweden) was also used for PCA model creation
and visualisation of principle components during the ex-
ploratory phase of algorithm development.
Set theoretic analysis
Set theoretic analysis (intersects, differences, and sizes) of
the gene sets and pathway results sets was done in Perl
with the use of the Set::Scalar library v 1.25 [17].
Graph theoretic analysis
Graph theoretic analysis was done in Perl with the use
of the Graph library v. 0.94 [18].
Threshold-based set creation algorithm
As became clear from examining the PCA score plots, as
well as plots of scores across all components, a gene or
group of genes may have different scores in different prin-
cipal components. As such, we decided to create sets at a
number of different thresholds to investigate whether this
approach would give more or less sensitivity in gene set
analysis. Thus for each principal component the positive
scores were compared against a series of integer thresh-
olds (1 through 10) and if the score at a principal compo-
nent was greater than the threshold it was added to a set
created for that principal component. A similar procedure
was followed for the negative scores at each principal
component with the score required to be less than the
negation of the integer threshold. Genes in these sets were
then mapped to Affymetrix probeset ids with the use
of the aforementioned Affymetrix-probeset-to-Genome
graph (described elsewhere in the Methods section), and
the matched probes substituted for the genes in the set.
Sets that contained more than, or equal to, five probeset
ids were kept for further analysis. The resulting sets were
subsequently printed out in the .gmt set format used by
Efron and Tibshiran (2007) [11]. This algorithm was
implemented in Perl.
Step-function-based set creation algorithm
In a separate effort to determine the effects of groups of
genes clustering at distinct score ranges within each
component on gene set creation and performance an
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tial empty score-range set was created as an array and
held in memory. Scores at each component were sorted
in numerical rank order. For positive scores greater than
one, neighbouring rank order scores were subtracted
from one another and if the difference was < 1 they were
added to the existing score-range set, if the difference
was > 1 the a existing score-range set was closed and a
new one (for the next score range) was created and the
new gene added to it. This process was repeated across
all of the scores in each principle component. A similar
procedure was used for the negative scores less than
negative one. This algorithm was implemented in Perl.Gene set analysis with newly generated sets
We used the sets created by the Laplacian PCA method
described above for the max-mean method by Efron and
Tibshiran (2007) [11]. In order to test the new sets on a
data set that would likely have a limited number of sub-
tle changes on metabolism, we selected a data set that
examined the effect of an O-glycosylation inhibitor,
OGT2468, on gene expression deposited by Javier
Arroyo. They used the Saccharomyces cerevisiae strain
SEY6210 and analysed the global transcriptome in the
absence of the OGT2468 (but with the corresponding
amount of DMSO, 0.1%) and in the presence of 0.1 μM
of OGT2468. They report that “yeast cells exposed to
OGT2468 in YPD growth medium show a significant in-
hibition of mating, filamentation and induction of cell
wall compensatory mechanism.” The resulting micro-
array data was downloaded from the Gene Expression
Omnibus (series id GSE12193) [19]. Specifically, the
microarrays used were those for the DMSO control
(GSM306567, GSM306565, GSM306569) vs. the cells
treated with 0.1 μM of OGT2468 (GSM306573,
GSM306577, GSM306581). The microarray data was
normalised in R with the RMA method [20] and the
resulting log2 transformed data used for GSA. GSA was
performed on this data with the following settings: resp.
type = "Two class unpaired", nperms = 1000, minsize =
2 and FDR cut = 0.05. The GSA analysis for the largest
number of sets (3481 Threshold 1 sets) ran in 2.3 min-
utes on a single CPU Intel Xeon E5620 2.40 GHz CPU.
The genes found in the sets created at PCA score
thresholds 1 through 10 which were determined to be
differentially expressed by GSA were tested with the
hypergeometric test described above. The genes selected
by this test were then used to create genes-only and
compounds-containing pathway-centric graphs as
described below. These graphs were visualised in cytos-
cape. Fold change values were calculated as the ratio of
the average expression values for the samples containing
0.1 μM of OGT2468 to the DMSO controls, and used asnode attributes to colour the gene nodes in cytoscape.
The negative reciprocal was taken of ratios less than 1.
Hypergeometric enrichment test to determine genes
most responsible for set selection
In order to determine which genes identified by GSA on
our newly derived sets are drivers we implemented a
hypergeometric test. The probability (p) of obtaining any
















is the binomial distribution, a = Number
of times the gene is found in significant sets; b = Num-
ber of times all other genes are found in significant sets;
c = Number of times the gene is found in non-
significant sets; d = Number of times all other genes are
found in non-significant sets, and n = a + b + c + d. A
Perl program was written to parse each of the gene set
analysis results as well as the original sets used for the
analysis after thresholding, and from these two sources
calculate a, b, c, d and n. The two tailed Fisher module
of the Text::NSP Perl package [21] was used to test for
significance using these values and multiple hypothesis
testing corrected for with the Holm-Bonferroni method
[22]. Genes with a q-value less than or equal to 0.1 were
reported as significantly enriched (i.e. drivers) and
included in a pathway-centric network reconstruction
for visualisation and interpretation.
Pathway-centric network reconstruction for visualisation
and interpretation
As was mentioned in the introduction, pathways are
really human abstractions of subgraphs of a metabolic
network that are particularly useful as mnemonic devices
for contextual visualisation. Unfortunately, visualizing
the network with all of the reaction, compound gene
and pathway nodes present is overwhelming and as such
difficult to interpret. If a biologist can see that the genes
selected are part of a well-known pathway it helps them
to interpret what part of the metabolic network they are
examining. By evaluating the results in this linked meta-
bolic context, one is able to see relationships between
areas of metabolism that simply would not be apparent
by looking at lists of genes or lists of pathways. Thus, we
have created two types of visualisations in order to bet-
ter show the metabolic context of the results. The first
visualisation just contains the significant genes and the
pathways that they are associated with. This is a useful
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ever, there are cases where related pathways are affected
but do not show up as connected without the com-
pounds being included in the network. Inclusion of all of
the compounds leads to a very complex figure so we
have chosen to simply create a single edge between
pathways if they share one or more compounds.
Raw KEGG XML files actually pre-group all genes,
reactions and compounds into these contextualised
pathways. In order to provide these sorts of visualisation
cues a pathway-centric view of the metabolic network
was therefore constructed as follows:
A Perl program was written to parse the KEGG XML
files such that a node was created for each pathway as
defined in KEGG. An edge was created between the path-
way node and each gene or compound that is associated
with that pathway. A gene determined to be significant by
GSA and the subsequent hypergeometric test was used as
a seed for a breadth first search of the pathway-centric
graph with a radius of one. This was done iteratively for
each gene and the union taken of the resulting subgraphs
(for examples of outputs see Figure 2). A similar proced-
ure was followed for the compound-linked-pathways view
with the additional step of the creation of a single edge be-
tween pathways that shared one or more compound.
Genes-only and compounds-containing graphs
Two different graphs were then created, one with and
one without compounds. For the genes-only graph, com-
pounds and their associated edges were simply removed
from the graph. The compounds-containing graph was
constructed by removing all compounds with a degree
less than two, such that compounds only served to link
pathway nodes together. The genes-only view of the
graph is easier to visualise and interpret whereas the
graph containing pathway-linking compounds was useful
in showing the connectedness (or lack thereof ) of the
subgraphs containing differentially expressed genes.
Gene Ontology and Funcat enrichment analysis
Genes that were found by the threshold 1 method but not
by the pathway GSA were checked for GO Enrichment by
GOEAST [23] and FunCat Enrichment at MIPS [24].
Results and discussion
Graph representation of a metabolic network
Mathematically, a metabolic network can be represented
as a graph, G = (V,E), where V is a set of n nodes and
E a set of e edges (connections) between nodes. Let A
(G) = A be the adjacency matrix of G such that each
element Aij is assigned a value of one if the correspond-
ing nodes are adjacent and zero if they are not. The
graph can be further described by a Laplacian transformof the adjacency matrix. The Laplacian matrix L(li,j)nxnis
defined as:
li;j:¼
deg v ið Þð Þif i ¼ j




where deg(v(i)) denotes the degree of v(i), i.e. the
number of edges incident to (i). Thus, the Laplacian
Matrix is the difference between the diagonal Degree
Matrix (D) and the Adjacency Matrix (A).
L = D - A
A number of graph theoretic properties of a graph can
be derived from its Laplacian matrix and the eigenvector
and eigenvalues thereof, including the number of con-
nected components in the graph; its algebraic connectiv-
ity (Fielder value); its spectral gap, etc. In fact, the PCA
of a graph and spectral graph clustering have been
linked previously by Saerens et al. [25].Principle component analysis
Given a matrix, one can use multivariate statistical methods
such a Principal Component Analysis (PCA) to try and find
correlative relationships amongst the vectors. PCA is a
bilinear modelling method which gives a visually interpret-
able overview of the most salient information in large,
multidimensional datasets. By plotting the principal compo-
nents it is possible to view statistical relationships between
different variables in complex datasets and detect and inter-
pret object groupings, similarities or differences, as well as
the relationships between the different variables [26]. As
described in the Methods section a graph was created from
the KEGG database [15] and a Laplacian matrix derived
from said graph. The Laplacian matrix produced, while not
a typical object-variable data matrix, may still be analysed
with multivariate methods. It was hypothesised that a princi-
pal component model would enumerate groups of nodes
within the graph with similar topological structure, with the
thought that similar columns within the Laplacian matrix
would explain a certain amount of ‘variance’ in the matrix.
Accordingly, we then performed PCA on the Laplacian
matrix with the hopes of finding an exhaustive set of struc-
tures within the graph that could be used for gene set
generation.Gene set generation with score thresholds and step-
functions
It was observed that the scores for each principal com-
ponent often generated discontinuous clusters of objects.
Two algorithms for set generation were therefore devel-
oped: one based on a step function that took the score
discontinuities into account; and another that specified
several predetermined thresholds. The sensitivity levels
of both these methods were subsequently compared.
These algorithms were used to generate gene sets from
Figure 2 Genes from PCA scores threshold = 1 derived sets found to be significantly differentially expressed in their pathway-centric
context. Nodes are coloured different intensities of blue (decrease) or red (increase) based on the fold change between treatment and control.
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nents (see Methods).Gene set analysis with new gene sets
We used the sets created by the Laplacian PCA method
described in the Methods section to perform the max-
mean method of GSA [11]. In order to test the new sets
on a dataset that would likely have a limited number of
subtle changes on metabolism, we selected a data set
that examined the effect of an O-glycosylation inhibitor.
The analysis was done as described in the Methods sec-
tion and the results described below.Hypergeometric enrichment test to determine genes
most responsible for set selection
One of the difficulties faced in Gene Set Analysis is that
it is unclear which of the genes within a set found to be
significantly and collectively different are most respon-
sible for that difference. This means that each significant
gene set likely has a subset of genes that really account
for the difference that is detected (“drivers”); and a sep-
arate subset of genes that do not significantly contribute
to the greater set’s difference (“passengers”). Fortunately,
due to the semi-exhaustive nature of our set creation al-
gorithm we have the ability to test for the likelihood of
set members being drivers or passengers. If a gene is
found in a number of significant sets at a considerably
higher frequency than one would expect to see at ran-
dom then it is more likely that the gene in question is a
driver. In order to determine which genes identified by
GSA using our newly derived sets are drivers we imple-
mented a hypergeometric test as described in the Meth-
ods section. Those genes considered to be drivers were
included in a pathway-centric network reconstruction
for visualisation and interpretation (see Methods) as
seen in Figures 2, 3, 4.High numbers of components are required to model a
metabolic laplacian matrix
First, we noticed upon examining the Laplacian PCA
model that it needed 2655 principal components to explain
all of the variance in the matrix (the same number of total
‘variables’ in the matrix). This is unusual as PCA models
are normally quite efficient at reducing the dimensionality
of a data set. In this case we believe that it suggests that
the model is likely semi-exhaustively explaining local struc-
tures in the graph. Additional file 1: Figure S1 is a plot of
the percentage of variance explained by each principle
component. It is easy to see from this plot that the variance
being modelled is spread out quite broadly over the 2655
components with almost all of the components individually
explaining less than 0.08% of the variance.Individual components model local areas of the graph
In order to test this hypothesis visually we extracted
nodes from each principle component and examined
their locations in the metabolic network. Figure 1 is an
overview of the metabolic network with the significant
nodes found in the first three principal components
(according to an imposed score threshold of 1), identi-
fied in green and their adjacent edges identified in red. It
is clear that the first three principal components are
identifying distinct, localised structures in the graph.
With the hypothesis that genes that are closely related
to one another in the metabolic network are likely to be
co-regulated we believe that each principal component
in the model is a candidate for one or more sets of genes
to be tested by GSA. To examine this further we looked
at the graph structures being located by many of the
principal components. We found that the principal com-
ponents are finding graph structures with highly con-
nected sets of genes that will likely be good candidates
for GSA. We continued this analysis through many
higher components of the model to confirm that this
was indeed occurring throughout a broad range of com-
ponents. To confirm this observation the distance be-
tween all genes in each set was determined and the
average distance within each set calculated to be 8.4.
Given that there is a distance of one between a gene and
the reaction it is associated with and a distance of two
(reaction to compound to next reaction) between reac-
tions, this means that in each set, on average, each gene
is being associated with genes involved the first, second
or third neighboring reactions. The distances between
all genes in the metabolic network have been calculated
and their sorted distribution is shown in Additional file
2: Figure S2. The red arrow indicates the average intra-
set gene distance. As such, the sets contain only about
20% of the possible gene pair distances. Thus, it appears
that sets are modelling relatively local topologies in the
network.
Semi-exhaustive nature of PCA-Graph gene set creation
We examined the distribution of PCA scores for each
gene in the model across all of the principal compo-
nents. Almost all genes participate in multiple principal
components. This indicates that sets generated from the
principal components from the PCA of the Metabolic
Laplacian matrix will be topologically exhaustive, that is
to say covering the combinatorial space as constrained
by the graph in an overlapping fashion. To confirm this
we examined the number of times that each gene was
found in sets created by a principal component score
threshold of one. Additional file 3: Figure S3 shows the
rank order distribution of the number of sets each gene
is a member of. Only two genes belong to only one set
and some genes belong to as many as 336 different sets.
Figure 3 Genes from PCA scores threshold = 1 derived sets found to be significantly differentially expressed in their pathway-centric
network reconstruction including edges between pathways that share at least one compound. Node colouring as described in Figure 2.
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be tested in combination with many other groups of
genes, which gives our method a higher likelihood of
finding co-regulated sets of genes. We checked the loca-
tion of the 20 genes that belong to the fewest gene sets
and found that they typically are either located in the ex-
treme leaf nodes of the large network or in the small dis-
connected subgraphs. Intuitively, this makes sense as
members of the outer extremities of the large network
and the disconnected subgraphs will be part of fewer
graph structure variants and therefore occur in fewer
principal components, and thus belong to fewer sets
derived from the principal component scores.
Degree of overlap amongst sets
In order to determine the level of overlap between the
sets generated by this approach an all-against-all com-
parison of the sets was done by way of set theoretic
intersects. For the 3481 sets generated at a score thresh-
old of one, an all-against-all comparison is comprised of
10,753,203 set intersects. The number of sets intersect-
ing with each individual set was calculated and plotted
(Additional file 4: Figure S4A). As can be seen fromFigure 4 Zoom in of the Genes and Pathways from Figure 3 that are
metabolism, Glycosylphosphatidylinositol(GPI)-anchor biosynthesis, In
Phosphatidylinositol signaling system. Node colouring as described in FAdditional file 4: Figure S4A many of the sets do have
intersects with one another ranging from as few as 2 to
as many as 2702. In order to achieve a semi-exhaustive
coverage of the graph’s local topology this sort of overlap
is desirable, as long as the degree of overlap is not so
high that the sets become effectively redundant. In order
to determine the degree of the overlap amongst sets the
size of each intersection was calculated, followed by
the number of set intersections of each respective size
(Additional file 4: Figure S4B). Of the 10,753,203 set
intersects performed, 8,225,500 showed no shared genes
at all, 1,125,959 shared one gene, and 519,333 shared 2
genes. As can be seen in Additional file 4: Figure S4B the
number of set intersections with higher degrees of overlap
drops very quickly. This would appear to be a very desir-
able result as it appears that the Laplacian PCA is yielding
sets that thoroughly cover local topological structures in
the graph without introducing an excessive level of over-
lap, i.e. redundancy, in the sets. As such the set intersec-
tion space is actually quite sparse as 80% of the potential
set intersections show no overlap at all. This again empha-
sizes that local topological structures in the graph are
being modelled by PCA, as one would not expect there toinvolved in Glycerolipid metabolism, Glycerophospholipid
ositol phosphate metabolism, N-Glycan biosynthesis, and the
igure 2.
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them) that are topologically separated from one another.
Set size
The sizes of the sets vary at each principal component
depending both on the region of the graph being mod-
elled by that component and the magnitude of the score
threshold employed. Additional file 5: Figure S5 shows
the distribution of set sizes when a score threshold of
+/− 1, 5 or 10 is used. The set sizes range from 5 to 92
members with an average set size of 27 genes.
Hypergeometric test
The hypergeometric test resulted in a ten-fold reduction
in the number of genes from the threshold 1 sets up to a
forty-nine-fold reduction from the threshold 5 sets, thus
simplifying the resulting network that needed to be
visualised and analysed.
Results from sets derived from different PCA score
thresholds
Sets created at different PCA thresholds naturally have
different set sizes and composition and as such may have
slightly different sensitivities in finding differential
changes in some portions of the metabolic network. The
threshold-based set generation algorithm produced
3481, 2703, 1487, 745, 331, 168, 80, 49 and 35 sets for
threshold 1, 2, 3, 4, 5, 6, 7, 8, 9, and 10 respectively for a
total of 11,216 sets.
In order to evaluate the efficacy of sets created at
different thresholds, a set theoretic approach was used
to determine the effects of these thresholds employed
during set generation on the pathways identified by
GSA. Lists (sets) of pathways with significant differ-
ences were generated from the results of GSA per-
formed with sets generated with PCA score thresholds
1 through 7 (see Methods). Thresholds 6 through 10
yielded no results after the application of the hyper-
geometric test. This is likely due to the relatively small
number of genes and sets generated at the higher
threshold levels. As such, there are insufficient differ-
ences in global and individual set frequencies for the
hypergeometric test to discriminate between driver and
passenger genes (i.e. to generate sufficiently low p-values).
The set theoretic difference was then determined between
the pathway sets resulting from PCA scores thresholds 2
through 5 as compared to the pathway set found using a
PCA scores threshold of 1.
All but one of the pathways found at thresholds 2
through 5 were also found with a threshold of 1, the one
exception being one gene in Aminoacyl-tRNA biosyn-
thesis found at threshold 3. As expected, the threshold 1
results contained many pathways not found at the other
thresholds, specifically: 11, 17, 22 and 24 more pathwayswere found with threshold 1 than with thresholds 2, 3, 4
or 5 respectively. However, as the different thresholds
contain subsets of the pathways and genes found in
threshold 1 they can be used as a ‘zoom-in, zoom-out’
method to view focused portions of the differentially
changed network. Figure 2 contains the results of sets
generated with a PCA scores threshold of 1. Figure 3 is
a slightly different view of the results, containing edges
between pathways that share one or more compounds.
Although somewhat more complex, it clearly shows the
linkages between genes in the result sets. Of note is the
connections between the pathways seen at the top of the
figure that show the connections between N-Glycan
biosynthesis, the Phosphatidylinositol signaling system,
Inositol phosphate metabolism, Glycerophospholipid
metabolism, Glycerolipid metabolism and Glycosylpho-
sphatidylinositol(GPI)-anchor biosynthesis (all but one
of which were missed by the single-pathway method)
which can be seen in more detail in Figure 4.
Comparison of threshold-based sets to step-function-
based sets
The step-function-based algorithm generated 1704 gene
sets. The lower number of sets generated is likely due to
the fact that the step-function identified many groupings
with less than five members which did not qualify as a set
for GSA purposes. The GSA results from sets generated
by the use of a step-function on PCA scores was com-
pared to the results generated at a score threshold of 1.
Similar to the threshold comparisons the step-function
identified three pathways (Cysteine & methionine metab-
olism, TCA cycle and Methane metabolism) not found by
the threshold 1 method. The threshold 1 method also
found 18 pathways that were not found by the step-
function method. This likely means that the entire positive
or negative branch of a principle component is accurately
modelling a topological structure and that subgraphs
within that topology are not generally needed to increase
the sensitivity of gene sets to be used for GSA.
Comparison of threshold 1 sets to single pathway sets
As has been discussed above, threshold 1 sets, with very
few exceptions, give the most complete view of differential
changes occurring in the metabolic network. In order to
compare this new set generation method to previous
approaches we created single pathway sets (see Methods)
which are the type of sets that have traditionally been used
in the past. We ran GSA on the 69 single pathway sets
described above and compared the results to those gener-
ated by the use of threshold 1 sets. The results of the sin-
gle pathway results can be seen in Figure 5. The single
pathway sets only identified 6 pathways as opposed to the
30 identified by the threshold 1 method. Additionally, be-
cause there is comparatively little overlap in the single
Figure 5 Results from single pathway sets.
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to determine which of the genes are drivers of the set stat-
istic and which are simply passengers. Furthermore, with
single pathway sets it is much harder to determine how
the sets are related to each other within the metabolic net-
work. It is clear that the results from Threshold 1 as pre-
sented in Figures 2, 3, 4 are much more comprehensive
that those from single pathway sets as presented in
Figure 5.
Single pathway sets found 20 (true positives) of the 76
genes found to be differentially expressed by the Thresh-
old 1 method, thus it missed 56 genes (false negatives)
found by the Threshold 1 method. Furthermore, it
included 111 apparent passenger genes (false positives)
that were present presumably because the pathway set
containing them was found to be significant and not be-
cause they contributed to the signal.
The results of the threshold 1 analysis could certainly be
presented as lists of genes or as lists of different pathways.
However, we are attempting to point out the limitations of
precisely this isolated pathway mode of thinking, the effects
of which have been noted elsewhere in the literature:
“The classical method of metabolic engineering, iden-
tifying a rate-determining step in a pathway and alleviat-
ing the bottleneck by enzyme overexpression, has
motivated much research but has enjoyed only limited
practical success. Intervention of other limiting steps, of
counter-balancing regulation, and of unknown coupled
pathways often confounds this direct approach [27].”
Thus, it would appear that there have been many
attempts at metabolic engineering in which researchers
have not taken into account the fact that pathways don’t
exist in isolation but are rather all interconnected. As
such, many attempts at metabolic engineering fail as
they are based on an overly simplistic model. Therefore,
we contend that seeing the genes in the context of the
metabolic network is a more accurate way to portray
and understand what is really occurring in metabolism.
Pathway names are very useful mnemonic devices to re-
mind one what area of metabolism is involved, but
should not be used to artificially isolate gene functions
from one another.
Our method finds differentially expressed genes involved
in N-Glycan biosynthesis, the Phosphatidylinositol signalling
system, Inositol phosphate metabolism, Glycerophospholi-
pid metabolism and Glycerolipid metabolism that were
missed by the single-pathway method. Furthermore, it
provides the visual context for how these pathways are
interlinked and how they are linked to Glycosylphosphatidy-
linositol(GPI)-anchor biosynthesis (the one related pathway
which the single pathway method does find). These findings
and the relationship between them would seem to be an im-
portant aspect of the biology that was missed by the single-
pathway approach.In addition, in order to determine the central biological
themes that our method found but were overlooked by the
single pathway GSA method, all of the genes that were
found by our method and not found with single pathway
GSA were subjected to GO Enrichment analysis and FunCat
Enrichment analysis as described in the Methods section.
Although it is beyond the scope of this paper to do a full
biological interpretation of these genes, we have discussed
them briefly below and included the full GO and FunCat
Enrichment results as Supplementary Material.
FunCat enrichment
The general categories of the functions that our method
finds that would have been missed previously include, as
identified by FunCat enrichment: amino acid metabolism,
nitrogen, sulphur and selenium metabolism, carbohydrate
metabolism, lipid, fatty acid and isoprenoid metabolism,
secondary metabolism, glycolysis and gluconeogenesis,
tricarboxylic-acid pathway (citrate cycle, Krebs cycle, TCA
cycle), metabolism of energy reserves (e.g. glycogen, trehal-
ose), complex cofactor/co-substrate/vitamin binding and
protein modification (N-glycosylation) [Additional file 6].
Gene Ontology enrichment
Simply looking at the GO Enrichment diagrams gives one a
good sense of how much pertinent biology was found with
our method that was missed by pathway GSA. It is clear
that we are finding core biological themes in N-linked pro-
tein glycosylation, which itself is interesting given that it was
O-linked glycosylation that was inhibited. In addition, lipid,
phospholipid and glycerophospholipid biosynthesis are
affected which links nicely with the enrichment for GPI an-
chor biosynthesis. There are further indications that
branched chain and aromatic acid metabolism is affected as
well as the TCA cycle and redox metabolism. Furthermore,
it is clear that there is an effect on a number of genes
involved in the cell wall, ER and plasma membranes, as one
would expect to see with the inhibition of protein glycosyla-
tion, which would be likely to affect a number of integral
membrane proteins [Additional file 7, Additional file 8 and
Additional file 9].
Differentially expressed genes
A list of the differentially expressed genes found by our
method, including their systematic and gene names as
well as their descriptions have been included as supple-
mentary material [Additional file 10].
Gene sets and software availability
The gene sets (affy probeset ids) generated by threshold
1 are included as supplementary material [Additional file
11]. Software used for the analysis is available upon re-
quest to the first author.
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To our knowledge there is no report in the literature of
the use of Principal Component Analysis of the Laplacian
matrix of a metabolic graph for any purpose, including set
generation for Gene Set Analysis. As such, it appears that
this is a novel method with which to find local topological
structures in metabolic networks. We have shown that
sets generated from the metabolic networks are semi-
exhaustive in that there are many partial set overlaps, but
the degree of overlap is relatively low. The fact that each
gene is a member of many sets allowed us to devise a
hypergeometric enrichment test to determine which genes
were likely to be driving the set statistic and which were
likely to simply be passengers, and could thus be pruned
away from the results set. We have further shown that the
structure represented by each signed half of each principal
component (greater than or equal to a score threshold of
1) is adequate for set generation. Further stratification of
each principal component, whether by threshold or step-
function methods did not significantly increase sensitivity.
However, the thresholding method did prove to be useful
as a ‘zoom-in, zoom-out’ function for biological interpret-
ation of the results. When compared to traditional path-
way sets this method appears to be much more sensitive
as it is a better representation of the underlying complex-
ity of a metabolic network. Furthermore, the method ap-
plied here allows one to see the full context of the genes
likely to be driving the set statistics rather than as simply
lists of pathways each containing an unknown number of
driver and passenger genes.
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